Page 1

ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email!

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 Published on March 2012

Report Summary Report Details Generic drugs - discover potentials and revenue prospects of companies, seeing what the future holds How are companies in the generics market performing' Visiongain's report gives you data, analyses and discussions for leading manufacturers of generic drugs. That new study lets you assess prominent companies in the generics market from 2012 to 2022. See how companies worldwide are performing and where they are heading. There, you find analytical profiles for leading producers - activities, outlooks and prospects: ' Teva Pharmaceutical Industries ' Sandoz ' Mylan ' Actavis ' Hospira ' Watson ' Abbott ' Sanofi ' Ranbaxy ' Cipla ' Aspen ' Stada Arzneimittel ' Coverage of 38 other leading companies from around the world. See how generics manufacturers compare, finding out how they can compete from 2012. Our investigation gives you business research and analysis, including revenue forecasts to 2022. You discover commercial data, predictions and discussions for companies and the market in which they operate. Where is the generics market heading' Many opportunities exist, especially in Japan and developing countries. Generic substitution is rising in Europe and the US. Also, which producers will expand beyond their domestic and regional markets to become global forces for the manufacturing and sales of generic drugs' As our study shows, there are many companies breaking into new markets and expanding generic product ranges. Complex generics, with high market entry barriers, and biosimilar (follow-on biologic/protein) products will transform the generics industry and pharma markets. Many opportunities exist for drug companies with biotechnological capabilities. Our report shows and explains.

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 1/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! The patent cliff will result in many more of the pharmaceutical industry's blockbusters being opened to generic competition. Which generic drug producers can best seize opportunities from 2012 to 2022' You find answers now in our study. Company analysis, revenue forecasts and discussions of industry prospects In visiongain's report you find historical revenues, sales predictions, growth rates and market breakdowns. Also, you see discussions of companies, product portfolios and growth potential. You receive 215 tables and charts. Ten ways Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 helps you In particular, our study gives you the following knowledge on the topic: ' Assess 50 leading generics producers, discovering their activities and outlooks ' Discover market leaders in each region ' Receive analyses of leading companies, seeing revenue forecasts to 2022 ' View a comparative analysis of generics players ' Assess commercial prospects, market breakdowns and product offerings ' Find existing revenues and operational data for leading companies ' Review technological, regulatory and commercial developments, assessing trends and prospects ' Analyse prospects for generic drug launches ' Investigate competition and opportunities influencing revenues ' Find out what will stimulate and restrain the industry and market. There, you find quantitative and qualitative analyses with independent predictions. You receive information that only our report contains, staying informed on business intelligence. Gain business research and analysis on generic drug makers now Our study is for everybody needing industry and market analyses for generic drug companies. You find data, trends and answers there. Please order that report now. Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6

Table of Content Table of Contents 1. Executive Summary 1.1 Overview of Findings 1.2 Chapter Breakdown 1.3 Research and Analysis Methods 1.4 Scope of this Report 1.5 Overview: Top 50 Generic Drug Manufacturers 2. The Leading Generic Drug Manufacturer: Teva Pharmaceutical Industries, 2012-2022

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 2/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! 2.1 Teva's Generics Business, 2012 2.2 Regional Sales for Teva Generics, 2010-2011 2.3 Teva's M&A Strategy, 2012 2.4 Growth Forecast for Teva, 2012-2022 3. The Leading Big Pharma Generic Drug Manufacturers, 2012-2022 3.1 Novartis (Sandoz), 2012 3.1.1 Novartis' Generics Business, 2012 3.1.2 Sales Breakdown for Novartis Generics, 2010-2011 3.1.3 Growth Strategy for Novartis Generics, 2012-2022 3.1.4 Growth Forecast for Novartis Generics, 2012-2022 3.2 Abbott Laboratories, 2012 3.2.1 Abbott's Generics Business, 2012 3.2.2 Abbott's Position in the Emerging Markets, 2012 3.2.3 Growth Forecast for Abbott Generics, 2012-2022 3.3 Pfizer, 2012 3.3.1 Pfizer's Generics Business, 2012 3.3.2 Pfizer's Generics Growth Strategy, 2012 3.3.3 Growth Forecast for Pfizer Generics, 2012-2022 3.4 Sanofi, 2012 3.4.1 Sanofi's Generics Business, 2012 3.4.2 Sanofi's Generics Growth Strategy, 2012 3.4.3 Growth Forecast for Sanofi Generics, 2012-2022 3.5 Takeda, 2012 3.5.1 Business Segments of Nycomed, 2011 4. The Leading North American Generic Drug Manufacturers, 2012-2022 4.1 Mylan, 2012 4.1.1 Mylan's Generics Business, 2012 4.1.2 Mylan's Regional Presence, 2012 4.1.3 Growth Forecast for Mylan Generics, 2012-2022 4.2 Hospira, 2012 4.2.1 Hospira's Generics Business, 2012 4.2.2 Hospira Growth Strategies, 2012 4.2.3 Growth Forecast for Hospira Generics, 2012-2022 4.3 Watson Pharmaceuticals, 2012 4.3.1 Watson's Generics Business, 2012 4.3.2 Watson's Growth Strategies, 2012 4.3.3 Growth Forecast for Watson Generics, 2012-2022 4.4 Par Pharmaceutical, 2012 4.4.1 Par's Generics Business, 2012 4.4.2 Par's Growth Strategy, 2012 4.4.3 Litigation Involving Par to 2012 4.5 Apotex, 2012 4.5.1 Apotex's Generics Business, 2012 4.5.2 Apotex in the Canadian Generics Market, 2012 4.5.3 Key Apotex Generic Launches, 2011 4.6 Impax Laboratories, 2012

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 3/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! 4.6.1 Impax's Generics Business, 2012 4.7 Covidien (Mallinckrodt), 2012 4.7.1 Mallinckrodt Generics, 2012 4.7.2 Litigation Involving Mallinckrodt 4.8 Pharmascience, 2012 4.8.1 Pharmascience's Generics Business, 2012 4.8.2 Pharmascience's Growth Strategies, 2012 4.9 Perrigo Company, 2012 4.9.1 Perrigo's Generics Business, 2012 4.9.2 Growth Prospects for Perrigo's Generics Business, 2012 4.10 Hi-Tech Pharmacal, 2012 4.10.1 Hi-Tech's Generics Business, 2012 4.10.2 Growth Prospects for Hi-Tech, 2012 4.11 Other North American Generics Companies, 2012 5. The Leading European Generic Drug Manufacturers, 2012-2022 5.1 Actavis, 2012 5.1.1 Actavis' Generics Business, 2012 5.1.2 Actavis' Generics Growth Strategy, 2012 5.1.3 Growth Forecast for Actavis Generics, 2012-2022 5.2 Fresenius Kabi, 2012 5.2.1 Fresenius Kabi's Generics Business, 2012 5.2.2 Growth Strategies for Fresenius Kabi, 2012 5.2.3 Growth Forecast for Fresenius Kabi Generics, 2012-2022 5.3 Stada Arzneimittel, 2012 5.3.1 Stada's Generics Business, 2012 5.3.2 Stada's Growth Prospects, 2012 5.3.3 Growth Forecast for Stada Arzneimittel Generics, 2012-2022 5.4 Gedeon Richter, 2012 5.4.1 Gedeon Richter's Generics Business, 2012 5.4.2 Regional Presence of Gedeon Richter, 2012 5.4.3 Growth Forecast for Gedeon Richter Generics, 2012-2022 5.5 Krka, 2012 5.5.1 Krka's Generics Business, 2012 5.5.2 Krka's Business Growth, 2012 5.5.3 Growth Forecast for Krka Generics, 2012-2022 5.6 Alapis, 2012 5.6.1 Alapis' Generics Business, 2012 5.6.2 Alapis and the Greek Economic Crisis, 2009-2012 5.7 Pharmstandard, 2012 5.7.1 Pharmstandard's Generics Business, 2012 5.7.2 Pharmstandard's Growth Prospects, 2012 5.8 Egis Pharmaceuticals, 2012 5.8.1 Egis' Generics Business, 2012 5.8.2 Egis' Business Strategy, 2012 5.9 Angelini, 2012 5.9.1 Angelini's Generics Business, 2012 5.10 Orion, 2012

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 4/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! 5.10.1 Orion's Generics Business, 2012 5.10.2 Orion's Regional Strategy, 2012 5.11 Bilim Pharmaceuticals, 2012 5.11.1 Bilim's Generics Business, 2012 5.11.2 Growth Prospects for Bilim 5.12 Veropharm, 2012 5.12.1 Growth Prospects for Veropharm's Generics Business, 2012 5.13 Elpen Pharmaceutical, 2012 5.13.1 Elpen's Generics Business, 2012 5.14 Eastpharma, 2012 5.14.1 Eastpharma's Generics Business, 2012 5.15 Other European Generics Companies, 2012 6. The Leading Indian Generic Drug Manufacturers, 2012-2022 6.1 Ranbaxy Laboratories, 2012 6.1.1 Ranbaxy's Generics Business, 2012 6.1.2 Ranbaxy's Growth Ambitions, 2012 6.1.3 Growth Forecast for Ranbaxy Generics, 2012-2022 6.2 Cipla, 2012 6.2.1 Cipla's Generics Business, 2012 6.2.2 Cipla and Patent Controversies, 2012 6.2.3 Growth Forecast for Cipla Generics, 2012-2022 6.3 Dr. Reddy's Laboratories, 2012 6.3.1 Dr. Reddy's Generics Business, 2012 6.3.2 Dr. Reddy's Regional Focus, 2012 6.3.3 Growth Forecast for Dr. Reddy's Generics, 2012-2022 6.4 Sun Pharma, 2012 6.4.1 Sun's Generics Business, 2012 6.4.2 Sun's Exports, 2012 6.4.3 Growth Forecast for Sun Pharma Generics, 2012-2022 6.5 Lupin, 2012 6.5.1 Lupin's Generics Business, 2012 6.5.2 Lupin's Regional Expansion, 2012 6.5.3 Growth Forecast for Lupin Generics, 2012-2022 6.6 Wockhardt, 2012 6.6.1 Wockhardt's Generics Business, 2012 6.7 Aurobindo, 2012 6.7.1 Aurobindo's Generics Business, 2012 6.8 Zydus Cadila, 2012 6.8.1 Zydus Cadila's Generics Business, 2012 6.9 Biocon, 2012 6.9.1 Biocon's Generics Business, 2012 6.9.2 Biocon's Collaborations, 2012 6.10 Strides Arcolab, 2012 6.10.1 Strides' Generics Business, 2012 6.10.2 Strides' Business Partnerships, 2012 6.11 Glenmark Pharmaceutical, 2012 6.11.1 Glenmark's Generics Business, 2012

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 5/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! 6.11.2 Future Business Direction for Glenmark, 2012 6.12 Other Indian Generics Manufacturers, 2012 7. The Leading Generic Drug Manufacturers in the Rest of the World, 2012-2022 7.1 Aspen Pharma, 2012 7.1.1 Aspen's Generics Business, 2012 7.1.2 Aspen's Regional Presence, 2012 7.1.3 Growth Forecast for Aspen Pharma Generics, 2012-2022 7.2 Hikma Pharmaceuticals, 2012 7.2.1 Hikma's Generics Business and Growth Prospects, 2012 7.3 Sawai Pharmaceutical, 2012 7.3.1 Sawai's Generics Business and Prospects, 2012 7.4 Nichi-Iko Pharmaceutical Co., 2012 7.4.1 Nichi-Iko's Generic Business and Prospects, 2012 7.5 Towa Pharmaceutical, 2012 7.5.1 Towa's Generics Business and Prospects, 2012 7.6 Nippon Chemiphar, 2012 7.6.1 Chemiphar's Generics Business and Prospects, 2012 7.7 LG Life Sciences, 2012 7.7.1 LG Life Sciences' Generics Business and Prospects, 2012 7.8 EMS Sigma, 2012 7.8.1 EMS Sigma's Generics Business and Prospects, 2012 7.9 Eurofarma, 2012 7.9.1 Eurofarma's Generics Business and Prospects, 2012 List of Tables Table 1.1 Top 50 Generic Pharmaceutical Manufacturers: Revenues ($m) and Ranking, 2010 Table 2.1 Teva Pharmaceutical Industries: Overview, 2010 Table 2.2 Top Ten Generics Sector M&A Deals (Teva Deals Highlighted), 2004-Q1 2012 Table 2.3 Teva Pharmaceutical Industries: Generic Revenues ($m), AGR (%), CAGR (%), 2010-2015 Table 2.4 Teva Pharmaceutical Industries: Generic Revenues ($m), AGR (%), CAGR (%), 2016-2022 Table 3.1 Novartis: Overview, 2010 Table 3.2 Novartis: Generic Revenues ($m), AGR (%), CAGR (%), 2010-2015 Table 3.3 Novartis: Generic Revenues ($m), AGR (%), CAGR (%), 2016-2022 Table 3.4 Abbott Laboratories: Overview, 2010 Table 3.5 Abbott: Generic Revenues ($m), AGR (%), CAGR (%), 2010-2015 Table 3.6 Abbott: Generic Revenues ($m), AGR (%), CAGR (%), 2016-2022 Table 3.7 Pfizer: Overview, 2010 Table 3.8 Pfizer: Generic Revenues ($m), AGR (%), CAGR (%), 2010-2015 Table 3.9 Pfizer: Generic Revenues ($m), AGR (%), CAGR (%), 2016-2022 Table 3.10 Sanofi: Overview, 2010 Table 3.11 Sanofi: Generic Revenues ($m), AGR (%), CAGR (%), 2010-2015 Table 3.12 Sanofi: Generic Revenues ($m), AGR (%), CAGR (%), 2016-2022 Table 3.13 Takeda: Overview, 2010 Table 4.1 Mylan: Overview, 2010 Table 4.2 Mylan: Generic Revenues ($m), AGR (%), CAGR (%), 2010-2015 Table 4.3 Mylan: Generic Revenues ($m), AGR (%), CAGR (%), 2016-2022

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 6/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Table 4.4 Hospira: Overview, 2010 Table 4.5 Hospira: Generic Revenues ($m), AGR (%), CAGR (%), 2010-2015 Table 4.6 Hospira: Generic Revenues ($m), AGR (%), CAGR (%), 2016-2022 Table 4.7 Watson: Overview, 2010 Table 4.8 Some Key Watson Generic Products, 2012 Table 4.9 Watson: Generic Revenues ($m), AGR (%), CAGR (%), 2010-2015 Table 4.10 Watson: Generic Revenues ($m), AGR (%), CAGR (%), 2016-2022 Table 4.11 Par Pharmaceutical: Overview, 2010 Table 4.12 Apotex: Overview, 2010 Table 4.13 Impax Laboratories: Overview, 2010 Table 4.14 Covidien: Overview, 2010 Table 4.15 Mallinckrodt Covidien Speciality Generics: Some Key Product Families, 2012 Table 4.16 Pharmascience: Overview, 2010 Table 4.17 Pharmascience Product Dossiers Registered in One or More EU State, 2012 Table 4.18 Perrigo Company: Overview, 2010 Table 4.19 High-Tech Pharmacal: Overview, 2010 Table 4.20 Selected Other North American Generic Companies, 2012 Table 5.1 Actavis: Overview, 2010 Table 5.2 Actavis: Generic Revenues ($m), AGR (%), CAGR (%), 2010-2015 Table 5.3 Actavis: Generic Revenues ($m), AGR (%), CAGR (%), 2016-2022 Table 5.4 Fresenius Kabi: Overview, 2010 Table 5.5 Fresenius Kabi: Generic Revenues ($m), AGR (%), CAGR (%), 2010-2015 Table 5.6 Fresenius Kabi: Generic Revenues ($m), AGR (%), CAGR (%), 2016-2022 Table 5.7 Stada Arzneimittel: Overview, 2010 Table 5.8 Stada: Generic Revenues ($m), AGR (%), CAGR (%), 2010-2015 Table 5.9 Stada: Generic Revenues ($m), AGR (%), CAGR (%), 2016-2022 Table 5.10 Gedeon Richter: Overview, 2010 Table 5.11 Gedeon Richter: Generic Revenues ($m), AGR (%), CAGR (%), 2010-2015 Table 5.12 Gedeon Richter: Generic Revenues ($m), AGR (%), CAGR (%), 2016-2022 Table 5.13 Krka: Overview, 2010 Table 5.14 Krka: Generic Revenues ($m), AGR (%), CAGR (%), 2010-2015 Table 5.15 Krka: Generic Revenues ($m), AGR (%), CAGR (%), 2016-2022 Table 5.16 Alapis: Overview, 2010 Table 5.17 Pharmstandard: Overview, 2010 Table 5.18 Egis: Overview, 2010 Table 5.19 Angelini: Overview, 2010 Table 5.20 Italian Drug Reimbursement Classes, 2012 Table 5.21 Orion: Overview, 2010 Table 5.22 Bilim Pharmaceuticals: Overview, 2010 Table 5.23 Veropharm: Overview, 2010 Table 5.24 Elpen Pharmaceutical: Overview, 2010 Table 5.25 Leading Elpen Generics, 2011 Table 5.26 EastPharma Pharmaceutical: Overview, 2010 Table 5.27 Leading EastPharma Generics, 2011 Table 5.28 Selected Other European Generics Companies, 2012 Table 6.1 Ranbaxy: Overview, 2010 Table 6.2 Ranbaxy: Top 10 Products, 2010 Table 6.3 Ranbaxy: Top 10 Therapeutic Areas, 2010

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 7/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Table 6.4 Ranbaxy: Generic Revenues ($m), AGR (%), CAGR (%), 2010-2015 Table 6.5 Ranbaxy: Generic Revenues ($m), AGR (%), CAGR (%), 2016-2022 Table 6.6 Cipla: Overview, 2010 Table 6.7 Cipla: Subsidiaries and Affiliates, 2010 Table 6.8 Cipla: Generic Revenues ($m), AGR (%), CAGR (%), 2010-2015 Table 6.9 Cipla: Generic Revenues ($m), AGR (%), CAGR (%), 2016-2022 Table 6.10 Dr. Reddy's: Overview, 2010 Table 6.11 Dr. Reddy's: Generic Revenues ($m), AGR (%), CAGR (%), 2010-2015 Table 6.12 Dr. Reddy's: Generic Revenues ($m), AGR (%), CAGR (%), 2016-2022 Table 6.13 Sun Pharma: Overview, 2010 Table 6.14 Sun Pharma: Generic Revenues ($m), AGR (%), CAGR (%), 2010-2015 Table 6.15 Sun Pharma: Generic Revenues ($m), AGR (%), CAGR (%), 2016-2022 Table 6.16 Lupin: Overview, 2010 Table 6.17 Lupin: Generic Revenues ($m), AGR (%), CAGR (%), 2010-2015 Table 6.18 Lupin: Generic Revenues ($m), AGR (%), CAGR (%), 2016-2022 Table 6.19 Wockhardt: Overview, 2010 Table 6.20 Aurobindo: Overview, 2010 Table 6.21 Zydus Cadila: Overview, 2010 Table 6.22 Biocon: Overview, 2010 Table 6.23 Strides Arcolab: Overview, 2010 Table 6.24 Glenmark: Overview, 2010 Table 7.1 Aspen Pharma: Overview, 2010 Table 7.2 Aspen: Generic Revenues ($m), AGR (%), CAGR (%), 2010-2015 Table 7.3 Aspen: Generic Revenues ($m), AGR (%), CAGR (%), 2016-2022 Table 7.4 Hikma: Overview, 2010 Table 7.5 Sawai: Overview, 2010 Table 7.6 Nichi-Iko: Overview, 2010 Table 7.7 Towa: Overview, 2010 Table 7.8 Nippon Chemiphar: Overview, 2010 Table 7.9 LG Life Sciences: Overview, 2010 Table 7.10 EMS Sigma: Overview, 2010 Table 7.11 Eurofarma: Overview, 2010 List of Figures Figure 2.1 Teva Pharmaceutical Industries: Business Segments Revenue Breakdown (%), 2010 Figure 2.2 Teva Pharmaceutical Industries: Generic Sales ($m), Regional Breakdown, 2011 Figure 2.3 Teva Pharmaceutical Industries: Generic Sales ($m), Quarterly Breakdown, 2011 Figure 2.4 Teva Pharmaceutical Industries: Generic Revenues ($m), 2010-2015 Figure 2.5 Teva Pharmaceutical Industries: Generic Revenues ($m), 2016-2022 Figure 3.1 Novartis: Business Segments Revenue Breakdown (%), 2011 Figure 3.2 Novartis: Generic Revenue Breakdown (%), 2011 Figure 3.3 Novartis: Generic Revenues ($m), 2010-2015 Figure 3.4 Novartis: Generic Revenues ($m), 2016-2022 Figure 3.5 Abbott: Business Segments Revenue Breakdown (%), 2010 Figure 3.6 Abbott: Generic Revenues ($m), 2010-2015 Figure 3.7 Abbott: Generic Revenues ($m), 2016-2022 Figure 3.8 Pfizer: Business Segments Revenue Breakdown (%), 2010

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 8/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Figure 3.9 Pfizer: Generic Revenues ($m), 2010-2015 Figure 3.10 Pfizer: Generic Revenues ($m), 2016-2022 Figure 3.11 Sanofi: Pharmaceutical Business Segments Revenue Breakdown (%), 2010 Figure 3.12 Sanofi: Generic Revenues ($m), 2010-2015 Figure 3.13 Sanofi: Generic Revenues ($m), 2016-2022 Figure 4.1 Mylan: Revenue Breakdown by Therapeutic Area (%), 2011 Figure 4.2 Mylan: Revenue Breakdown by Business Segment (%), 2011 Figure 4.3 Mylan: Generic Revenues ($m), 2010-2015 Figure 4.4 Mylan: Generic Revenues ($m), 2016-2022 Figure 4.5 Hospira: Revenue Breakdown by Business Segment (%), 2010 Figure 4.6 Hospira: Specialty Injectables Revenue Breakdown by Region (%), 2010 Figure 4.7 Hospira: Generic Revenues ($m), 2010-2015 Figure 4.8 Hospira: Generic Revenues ($m), 2016-2022 Figure 4.9 Watson: Revenue Breakdown by Business Segment (%), 2010 Figure 4.10 Watson: Generic Revenues ($m), 2010-2015 Figure 4.11 Watson: Generic Revenues ($m), 2016-2022 Figure 4.12 Par Generics: Revenue Breakdown by Customer (%), 2010 Figure 4.13 Generic Share in Canadian Market by Revenue (%), 2010 Figure 4.14 Generic Share in Canadian Market by Prescription Volume (%), 2005-2010 Figure 4.15 Impax Sales Channel Revenue Breakdown (%), 2010 Figure 4.16 Impax Generics: Revenue Breakdown by Customer (%), 2010 Figure 4.17 Perrigo Company: Revenue Breakdown by Business Segment (%), 2011 Figure 4.18 Hi-Tech Pharmacal: Revenue Breakdown by Business Segment (%), 2010 Figure 5.1 Actavis: Generic Revenues ($m), 2010-2015 Figure 5.2 Actavis: Generic Revenues ($m), 2016-2022 Figure 5.3 Fresenius SE: Revenue Breakdown by Company (%), 2011 Figure 5.4 Fresenius Kabi: Revenue Breakdown by Business Segment (%), 2010 Figure 5.5 Fresenius Kabi: Revenue Breakdown by Region (%), 2011 Figure 5.6 Fresenius Kabi: Generic Revenues ($m), 2010-2015 Figure 5.7 Fresenius Kabi: Generic Revenues ($m), 2016-2022 Figure 5.8 Stada: Revenue Breakdown by Business Segment (%), 2010 Figure 5.9 Stada: Distribution of Costs (%), 2010 Figure 5.10 Stada: Revenue Breakdown by Region (%), 2010 Figure 5.11 Stada: Generic Revenues ($m), 2010-2015 Figure 5.12 Stada: Generic Revenues ($m), 2016-2022 Figure 5.13 Gedeon Richter: Ownership of the Company (%), 2012 Figure 5.14 Gedeon Richter: Revenue Breakdown by Business Segment, 2010 Figure 5.15 Gedeon Richter: Revenue Breakdown by Therapeutic Area, 2010 Figure 5.16 Gedeon Richter: Revenue Breakdown by Region, 2010 Figure 5.17 Gedeon Richter: Generic Revenues ($m), 2010-2015 Figure 5.18 Gedeon Richter: Generic Revenues ($m), 2016-2022 Figure 5.19 Krka: Revenue Breakdown by Business Segment, 2011 Figure 5.20 Krka: Revenue Breakdown by Region, 2010 Figure 5.21 Krka: Revenue Breakdown by Therapeutic Area, 2010 Figure 5.22 Krka: Generic Revenues ($m), 2010-2015 Figure 5.23 Krka: Generic Revenues ($m), 2016-2022 Figure 5.24 Russian Pharmaceutical Market: Segmentation (%), 2010 Figure 5.25 Leading Companies in the Russian Pharmaceutical Market: Market Share (%), 2010

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 9/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Figure 5.26 Egis: Revenue Breakdown by Therapeutic Class, FY 2011 Figure 5.27 Egis: Revenue Breakdown by Region, FY 2011 Figure 5.28 Orion: Revenue Breakdown by Business Segment, 2011 Figure 5.29 Orion: Revenue Breakdown by Region, 2011 Figure 5.30 Turkish Pharmaceutical Market: Generic and Originator Products Share of Market by Volume (%), 2010 Figure 5.31 Turkish Pharmaceutical Market: Generic and Originator Products Share of Market by Revenue (%), 2010 Figure 5.32 Veropharm: Leading Prescription Drugs, Company Revenue Share (%), H1 2011 Figure 5.33 Veropharm: Traditional Products, Company Revenue Share (%), H1 2011 Figure 5.34 Veropharm: OTC Products, Company Revenue Share (%), H1 2011 Figure 5.35 Russia's Hospital Oncology Market: Leading Companies by Share (%), H1 2011 Figure 6.1 Ranbaxy: Revenue Breakdown by Region (%), 2010 Figure 6.2 Ranbaxy: Approvals and Filings by Region, 2010 Figure 6.3 Ranbaxy: Generic Revenues ($m), 2010-2015 Figure 6.4 Ranbaxy: Generic Revenues ($m), 2016-2022 Figure 6.5 Cipla: Export Revenues Breakdown by Region (%), 2010 Figure 6.6 Cipla: Generic Revenues ($m), 2010-2015 Figure 6.7 Cipla: Generic Revenues ($m), 2016-2022 Figure 6.8 Dr. Reddy's: Revenue Breakdown by Business Segment (%), 2010 Figure 6.9 Dr. Reddy's: Top Indian Generics Brands, Revenue Share (%) 2010 Figure 6.10 Dr. Reddy's: Revenue Breakdown by Region (%), 2010 Figure 6.11 Dr. Reddy's: Generic Revenues ($m), 2010-2015 Figure 6.12 Dr. Reddy's: Generic Revenues ($m), 2016-2022 Figure 6.13 Sun Pharma: Revenue Breakdown (%) by Business Segment, 2010 Figure 6.14 Sun Pharma: Indian Generics Revenue Breakdown (%) by Therapeutic Area, 2010 Figure 6.15 Sun Pharma: Cumulative ANDA Filings and Approvals, 2004-2011 Figure 6.16 Sun Pharma: Generic Revenues ($m), 2010-2015 Figure 6.17 Sun Pharma: Generic Revenues ($m), 2016-2022 Figure 6.18 Lupin: Breakdown by Business Segment, 2010 Figure 6.19 Lupin: Business Segment Share of Revenues (%), Lupin FY 2007-2011 Figure 6.20 Lupin: Export Markets Share of Revenues (%), Lupin FY 2007-2011 Figure 6.21 Lupin: Generic Revenues ($m), 2010-2015 Figure 6.22 Lupin: Generic Revenues ($m), 2016-2022 Figure 6.23 Wockhardt: Generic Revenues Breakdown by Region (%), 2010 Figure 6.24 Aurobindo: Generic Revenues Breakdown by Region (%), 2010 Figure 6.25 Aurobindo: Generic Drug Submissions and Approvals, Breakdown by Region (%), 2010 Figure 6.26 Zydus Cadila: Generic Revenues Breakdown by Region (%), 2010 Figure 6.27 Biocon: Revenue Breakdown by Business Segment, 2010 Figure 6.28 Strides Arcolab: ANDA Submissions and Approvals, Company FY 2005-2010 Figure 6.29 Glenmark: Revenue Breakdown by Business Segment (%), 2010 Figure 6.30 Glenmark: Generic Revenue Breakdown by Segment (%), 2010 Figure 7.1 Aspen Revenues Breakdown by Region (%), 2011 Figure 7.2 Aspen Revenue Growth by Region (%), 2011 Figure 7.3 South African Market by Company Share (%), June 2011 Figure 7.4 Aspen's Latin American Revenues: Breakdown by Country (%), June 2011 Figure 7.5 Aspen: Generic Revenues ($m), 2010-2015 Figure 7.6 Aspen: Generic Revenues ($m), 2016-2022 Figure 7.7 Hikma: Revenue Breakdown by Business Segment, 2010 Figure 7.8 Hikma: Revenue Breakdown by Region, 2010

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 10/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Figure 7.9 Sawai: Revenue Breakdown by Therapeutic Class, 2010 Figure 7.10 Sawai: Revenue Breakdown by Sales Channel, 2010 Figure 7.11 Nichi-Iko Generic Portfolio: Breakdown by Formulation, 2010 Figure 7.12 Nichi-Iko AGR (%), Company FY 2001-2010 Figure 7.13 Towa Revenue Breakdown by Therapeutic Class (%), FY 2010 Figure 7.14 Nippon Chemiphar Generic Revenues as Share of Overall Revenues, Company FY 2007-2010 Figure 7.15 Brazilian Pharmaceutical Market by Segment, 2010 Companies Listed AA Pharma Abbott Laboratories Able Labs Abraxis Bioscience Abrika Pharmaceuticals Aceto Corporation Actavis Active Pharma Adcock Ingram Aegera Therapeutics Alapis Alcon Alfred E. Tiefenbacher Almirall Prodesfarma Alnylam Pharmaceuticals Alphapharm Alpharma Altra Investments Amerigen Pharmaceuticals AmerisourceBergen Amgen Amide Pharmaceutical Amneal Pharmaceuticals Amylin Pharmaceuticals Anadys Pharmaceuticals Ancraf Andrx Corporation Angelini Angenerico Apicore ApoPharma Apotex APP Pharmaceuticals Aprogen aRigen Pharmaceuticals Arrow Generics Asahi Kasei Pharma Corporation Ascent Pharmahealth

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 11/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! ASKA Pharmaceutical Aspen Group Aspen Pharma Astellas AstraZeneca Aurobindo AxiCorp Sapient Discovery B. Braun Melsungen Balkanpharma Barr Pharmaceuticals Baxter Healthcare Baxter International Bayer Bayer Yakuhin Bedford Laboratories Beltapharm Biddle Sawyer Corporation Bilim Pharmaceuticals Bioceuticals Arzneimittel BioChimico Biocon Biogen Idec biomo pharma Bioniche Pharma BioTech Pharma BiotechCorp Bioton Biovail Laboratories Biovena Pharma Boehringer Ingelheim Bristol-Myers Squibb Bunker Industria Farmaceutica Cadila Healthcare Caraco Pharmaceutical Laboratories Cardinal Health CareFusion Celgene Corporation Celltrion Center of Molecular Immunology (Cuba) Cephalon Chattem Chemicals ChemGenex Chon Kun Dang Ciba-Geigy CIMA Labs Cipla Claris Lifesciences Clinton Foundation

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 12/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Cobalt Laboratories Colotech Combino Pharm CoPharma Corporacion Infarmasa Covidien CSC Pharmaceuticals CSFB Alternative Capital CVS Pharmacy Dabur Pharma Daiichi Sankyo Debiopharm Delta Pharma DepoMed Dey Pharma DoctorActive Dr. Reddy's Laboratories DuPont Crop Protection DURECT Corporation EastPharma Ebewe Pharma EBIK Eden Biopharm Egis Pharmaceuticals Elan Eli Lilly Elpen Pharmaceutical Elpharma Emcure Pharmaceuticals EMET Pharmaceuticals EMS Sigma Endo Pharmaceutical Ethex Corporation Eurodrug Laboratories Eurofarma Laboratorios European Central Bank European Generic Medicines Association (EGA) European Medicines Agency (EMEA/EMA) Eximas Fako Pharma Faran Laboratories Farmaprojects Federal Court of Canada Fidia farmaceutici Filaxis Fisiopharma Food and Drug Administration (US FDA) Fougera

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 13/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Fournier Fresenius Kabi Fresenius Medical Care Fuso Pharmaceutical Industries G&W Laboratories Galderma Gedeon Richter Genepharm Group Genericon Pharma Genéricos Españoles Genertec Group Genesoft Genzyme Germa Pharm GlaxoSmithKline Glenmark Graceway Pharmaceuticals Grindeks Grünenthal Grupo Azevedos Gujarat Lyka Organics Gyma Health Canada Helm Pharmaceuticals Help Helvepharm Helvetia Pharma Hexal Hikma Pharmaceuticals Hi-Tech Pharmacal HLJ.Haerbin Phar Hormosan Pharma Hospira HRA Pharma Human Genome Sciences Hungarian State Holding Company Hypermarcas Ibiopro Solutions Impax Laboratories Institut National de la Santé et de la Recherche Médicale (INSERM, France) Institut Pasteur Korea IntelliPharmaCeutics International Monetary Fund Invent Farma IPR Pharmaceuticals Italfarmaco Itero Biopharmaceuticals IVAX

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 14/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Janssen Javelin Pharmaceuticals Johnson & Johnson JS.L.Y.G. Hengr JS Yangzijiang Jubilant Life Science Kendall Kent Pharmaceuticals Ke Lun Group Kern Pharma Kiadis Pharma Kobrek Pharmaceuticals Korea Research Institute of Bioscience and Biotechnology Kowa Company Krka Kroger KV Pharmaceuticals Kyorin Pharmaceutical Labesfal Laboratoire Theramex Laboratories Besins Iscovesco Laboratorio Sanderson Laboratorio Teuto Brasileiro Laboratorios Cinf Laboratorios Kendrick LaborMed Pharma Lamda Detergent Lehigh Valley Technologies LG Life Sciences Lotos Laboratories Lundbeck Lupin Madaus Mallinckrodt Masterleik Matrix Laboratories Mayne Pharma McKesson Drug Company Medco Medeva Pharma Medimpex Medis Medley Medochemie Meiji Seika Pharma Menarini Merck & Co. Merck KGaA

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 15/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Midlothian Laboratories Millennium Pharmaceuticals Milmet Labs Mitani Sangyo Mitsubishi Tanabe Pharma MJ Pharma MN Pharmaceuticals Mochida Pharmaceutical Moksha8 Pharmaceuticals Momenta Pharmaceuticals Multicare Pharmaceuticals Mylan Myrallis Napp Pharmaceutical Nellcor neuraxpharm Nichi-Iko Pharmaceutical Co. Nihon Chouzai Nippon Chemiphar Nippon Kayaku Nordic Capital Normon Novartis Novel Laboratories Novo Nordisk Nycomed Ohm Laboratories Optimer Pharmaceuticals Orchid Chemicals & Pharmaceuticals Orion Ortho-McNeil-Janssen Paddock Laboratories Pangeo Par Pharmaceutical Perlecan Pharma Perrigo Company Pfizer Pharma Avalance Pharma Dynamics Pharmacia & Upjohn PharmaPack International Pharmascience Pharmstandard Phlox Pharma Pinewood Laboratories Piramal Healthcare Solutions Pliva Polfa Warszawa

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 16/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Polifarma Polpharma Pozen Pradeep Drug Company Prazzi-Donaduzzi Promius Pharma Pronova BioPharma ProStrakan Purdue Pharma Products Puritan-Bennett Pymepharco QRxPharma Ranbaxy Laboratories ratiopharm-Merckle Group Rega Farma de Produtos Remedica Rheoscience Rhodes Technologies Ribbon Richter-Helm Biologics Rite Aid Rivopharm Robin Hood Holdings Roche Rohatyn Group Ross Products Safety Syringes Safeway Sagent Pharmaceuticals Salomon Levin and Elstein Samsung Sandoz Sanofi Santarus Sawai Pharmaceutical Schering-Plough Schwarz Pharma Sekisui Medical SeQuent Scientific Servier Shandong Luoxin PH Shandong Ruiyang Shandong Qilu SH.Asia Pioneer PH Shelys Pharmaceuticals Shionogi Seiyaku Kabushki Kaisha Sicor Sindan

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 17/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! SK Chemicals Solvay Pharmaceuticals Somaxon Pharmaceuticals Sovereign Spear Spirig Pharma Stada Arzneimittel Stiefel Research Australia Streuli Pharma Strides Arcolab Sun Pharma Synageva Synthon Pharmaceutica Syrrx Taiyo Takeda Taro Pharmaceutical Industries Teuto Teva Pharmaceutical Industries Teva-Kowa Pharma Three Rivers Tolmar Towa Pharmaceutical Triax Pharmaceuticals Tris Pharma UCB Manufacturing Unimed Pharmaceuticals United Nations (UN) University of Aberdeen University of Athens University of Missouri University of Thessaly University of Tokyo Valeant Pharmaceuticals Valleylab Velefarm Veropharm Versapharm Veterin Vianex Vinchem Walgreens Walmart Warner Chilcott Watson Pharmaceuticals West Ward Winthrop Wockhardt

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 18/21


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! World Health Organization (WHO) Wyeth Zentiva Zhejiang Chiral Medicine Chemicals Zhuhai Lizhu Group ZiO Zdorovje Zydus Cadila Zydus Hospira Oncology

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 19/21


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ

Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93

If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information Please verify that the product information is correct and select the format(s) you require. Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022

Product Formats Please select the product formats and the quantity you require. 1 User License--USD 2 632.96

Quantity: _____

Department License--USD 4 646.40

Quantity: _____

Site License--USD 7 745.28

Quantity: _____

Corporate License--USD 10 844.16

Quantity: _____

Contact Information Please enter all the information below in BLOCK CAPITALS

Title:

Mr

Mrs

Dr

Miss

Ms

Prof

First Name:

_____________________________ Last Name: __________________________________

Email Address:

__________________________________________________________________________

Job Title:

__________________________________________________________________________

Organization:

__________________________________________________________________________

Address:

__________________________________________________________________________

City:

__________________________________________________________________________

Postal / Zip Code:

__________________________________________________________________________

Country:

__________________________________________________________________________

Phone Number:

__________________________________________________________________________

Fax Number:

__________________________________________________________________________

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 20/21


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card

Card Number: ______________________________________________

Expiry Date

__________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer

Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check

UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms

Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56

ƒ ƒ

Asia, Oceania and America : + 1 (805) 617 17 93

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022 (From Issuu)

Page 21/21

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022  

Report Summary Where is the generics market heading' Many opportunities exist, especially in Japan and developing countries. Generic substit...